Clinical Trial Update: Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study [Phase 4]

View source ↗

Summary

A multicenter Phase 4 trial evaluating rituximab maintenance after BR or RCHOP or R2 in newly diagnosed follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Ruijin Hospital | Conditions: Follicular Lymphoma | Phase 4 | Status: UNKNOWN